99 related articles for article (PubMed ID: 7917362)
21. Constitutive expression of the orphan receptor, Rev-erbA alpha, inhibits muscle differentiation and abrogates the expression of the myoD gene family.
Downes M; Carozzi AJ; Muscat GE
Mol Endocrinol; 1995 Dec; 9(12):1666-78. PubMed ID: 8614403
[TBL] [Abstract][Full Text] [Related]
22. Thyroid hormone and DNA binding properties of a mutant c-erbA beta receptor associated with generalized thyroid hormone resistance.
Usala SJ; Wondisford FE; Watson TL; Menke JB; Weintraub BD
Biochem Biophys Res Commun; 1990 Sep; 171(2):575-80. PubMed ID: 2169728
[TBL] [Abstract][Full Text] [Related]
23. Cloning of a thyroid hormone-responsive Rana catesbeiana c-erbA-beta gene.
Davey JC; Schneider MJ; Galton VA
Dev Genet; 1994; 15(4):339-46. PubMed ID: 7923937
[TBL] [Abstract][Full Text] [Related]
24. A point mutation (Ala229 to Thr) in the hinge domain of the c-erbA beta thyroid hormone receptor gene in a family with generalized thyroid hormone resistance.
Behr M; Loos U
Mol Endocrinol; 1992 Jul; 6(7):1119-26. PubMed ID: 1324420
[TBL] [Abstract][Full Text] [Related]
25. Identification of a thyroid hormone receptor that is pituitary-specific.
Hodin RA; Lazar MA; Wintman BI; Darling DS; Koenig RJ; Larsen PR; Moore DD; Chin WW
Science; 1989 Apr; 244(4900):76-9. PubMed ID: 2539642
[TBL] [Abstract][Full Text] [Related]
26. A new point mutation in the 3,5,3'-triiodothyronine-binding domain of the c-erbA beta thyroid hormone receptor is tightly linked to generalized thyroid hormone resistance.
Usala SJ; Menke JB; Watson TL; Bérard WE; Bradley C; Bale AE; Lash RW; Weintraub BD
J Clin Endocrinol Metab; 1991 Jan; 72(1):32-8. PubMed ID: 1846005
[TBL] [Abstract][Full Text] [Related]
27. Identification of a rat c-erbA alpha-related protein which binds deoxyribonucleic acid but does not bind thyroid hormone.
Lazar MA; Hodin RA; Darling DS; Chin WW
Mol Endocrinol; 1988 Oct; 2(10):893-901. PubMed ID: 2903438
[TBL] [Abstract][Full Text] [Related]
28. Characterization of site-specific polyclonal antibodies to c-erbA peptides recognizing human thyroid hormone receptors alpha 1, alpha 2, and beta and native 3,5,3'-triiodothyronine receptor, and study of tissue distribution of the antigen.
Macchia E; Nakai A; Janiga A; Sakurai A; Fisfalen ME; Gardner P; Soltani K; DeGroot LJ
Endocrinology; 1990 Jun; 126(6):3232-9. PubMed ID: 1693571
[TBL] [Abstract][Full Text] [Related]
29. Dominant and nondominant negative C-erbA beta 1 receptors associated with thyroid hormone resistance syndromes augment 12-O-tetradecanoyl-phorbol-13-acetate induction of the collagenase promoter and exhibit defective 3,5,3'-triiodothyronine-mediated repression.
Ways DK; Qin W; Cook P; Parker PJ; Menke JB; Hao E; Smith AM; Jones C; Hershman JM; Geffner ME
Mol Endocrinol; 1993 Sep; 7(9):1112-20. PubMed ID: 8247013
[TBL] [Abstract][Full Text] [Related]
30. Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.
Wahlström GM; Vennström B
Mol Endocrinol; 1998 May; 12(5):645-53. PubMed ID: 9605927
[TBL] [Abstract][Full Text] [Related]
31. Alternative splicing generates messages encoding rat c-erbA proteins that do not bind thyroid hormone.
Mitsuhashi T; Tennyson GE; Nikodem VM
Proc Natl Acad Sci U S A; 1988 Aug; 85(16):5804-8. PubMed ID: 2901090
[TBL] [Abstract][Full Text] [Related]
32. Close proximity of c-erbA2 and c-erbA-beta genes on the short arm of chromosome 3.
Ali IU; Saxena A; Meissner S; Barrick J; Lidereau R
Oncogene; 1993 Aug; 8(8):2299-301. PubMed ID: 8393165
[TBL] [Abstract][Full Text] [Related]
33. v-erbA overexpression is required to extinguish c-erbA function in erythroid cell differentiation and regulation of the erbA target gene CAII.
Disela C; Glineur C; Bugge T; Sap J; Stengl G; Dodgson J; Stunnenberg H; Beug H; Zenke M
Genes Dev; 1991 Nov; 5(11):2033-47. PubMed ID: 1682217
[TBL] [Abstract][Full Text] [Related]
34. Differential and tissue-specific regulation of the multiple rat c-erbA messenger RNA species by thyroid hormone.
Hodin RA; Lazar MA; Chin WW
J Clin Invest; 1990 Jan; 85(1):101-5. PubMed ID: 2153150
[TBL] [Abstract][Full Text] [Related]
35. Characterization of seven novel mutations of the c-erbA beta gene in unrelated kindreds with generalized thyroid hormone resistance. Evidence for two "hot spot" regions of the ligand binding domain.
Parrilla R; Mixson AJ; McPherson JA; McClaskey JH; Weintraub BD
J Clin Invest; 1991 Dec; 88(6):2123-30. PubMed ID: 1661299
[TBL] [Abstract][Full Text] [Related]
36. An arginine to histidine mutation in codon 311 of the C-erbA beta gene results in a mutant thyroid hormone receptor that does not mediate a dominant negative phenotype.
Geffner ME; Su F; Ross NS; Hershman JM; Van Dop C; Menke JB; Hao E; Stanzak RK; Eaton T; Samuels HH
J Clin Invest; 1993 Feb; 91(2):538-46. PubMed ID: 8381821
[TBL] [Abstract][Full Text] [Related]
37. Antibodies against restricted sequences in human c-ErbA hinge domain recognize differentially natural mammalian alpha- or beta-type triiodothyronine receptors and interfere differently with hormone binding.
Bismuth J; Lenoir C; Teboul M; Daadi M; Giorgilli G; Bonne J; Macchia E; Planells R; Torresani J
Eur J Endocrinol; 1995 Mar; 132(3):347-56. PubMed ID: 7889185
[TBL] [Abstract][Full Text] [Related]
38. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
Damm K; Evans RM
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
[TBL] [Abstract][Full Text] [Related]
39. The v-ErbA oncoprotein quenches the activity of an erythroid-specific enhancer.
Braliou GG; Ciana P; Klaassen W; Gandrillon O; Stunnenberg HG
Oncogene; 2001 Feb; 20(7):775-87. PubMed ID: 11314012
[TBL] [Abstract][Full Text] [Related]
40. Binding of 3,5,3'-triiodothyronine (T3) and its analogs to the in vitro translational products of c-erbA protooncogenes: differences in the affinity of the alpha- and beta-forms for the acetic acid analog and failure of the human testis and kidney alpha-2 products to bind T3.
Schueler PA; Schwartz HL; Strait KA; Mariash CN; Oppenheimer JH
Mol Endocrinol; 1990 Feb; 4(2):227-34. PubMed ID: 2158622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
